Pariet
5 customer reviewsPariet is a proton pump inhibitor with rabeprazole as its active ingredient. It is used for acid-related stomach and oesophageal conditions, where reducing acid helps relieve symptoms and support healing. It works by blocking the stomach’s proton pump so acid production falls.
What is it?
Pariet is a proton pump inhibitor that reduces stomach acid production. The effect happens inside the acid‑producing cells of the stomach lining, called parietal cells. Parietal cells make acid using an enzyme system often described as the “proton pump”; rabeprazole blocks this pump and lowers hydrochloric acid output.
Acid suppression matters for more than comfort. Lower acidity reduces chemical irritation in the oesophagus and gives ulcers a better environment to close and scar down, which is why PPIs are central therapy in reflux disease and ulcer healing [1].
Mechanism in plain pharmacy terms
Rabeprazole is acid‑labile, so Pariet tablets are designed to pass through the stomach and release the medicine where it can be absorbed and then concentrated in parietal cells. Inside those cells, rabeprazole binds to the proton pump and turns down acid secretion for a sustained period. Symptom relief can begin in the first few days, yet healing of erosive reflux or ulcers usually takes longer than symptom control.
Composition
Pariet contains rabeprazole sodium, a proton pump inhibitor used to reduce gastric acid production. The tablets also include standard excipients that support tablet stability and release, such as fillers, binders, disintegrants, and coating components. The exact inactive ingredients may vary by strength and manufacturing batch.
How to use?
Pariet is used to treat acid-related conditions, including gastroesophageal reflux disease, erosive reflux esophagitis, duodenal ulcer, and gastric ulcer. It is also used as part of combination therapy to help eradicate Helicobacter pylori and to manage Zollinger-Ellison syndrome when long-term acid suppression is needed.
How does it work?
Pariet works by blocking the gastric proton pump in the parietal cells of the stomach. This lowers the final step of acid secretion, reducing stomach acidity and helping relieve heartburn, pain, and acid damage to the esophagus or stomach lining. The effect supports healing of ulcers and inflammation caused by excess acid.
Indications
Pariet rabeprazole 20 mg is used for acid‑related gastrointestinal conditions where reducing acid supports symptom control and tissue healing:
- Gastro‑oesophageal reflux disease (GERD): for troublesome heartburn and acid regurgitation, including symptomatic reflux.
- Erosive oesophagitis: healing inflamed or eroded oesophageal lining, and maintenance after healing.
- Duodenal ulcer and gastric ulcer: treatment and healing as part of ulcer management.
- Helicobacter pylori (H. pylori) eradication: used in combination regimens with appropriate antibiotics to clear infection linked to ulcer disease [2].
A key limitation: Pariet treats acid and acid-driven injury, not every cause of upper‑abdominal discomfort. Persistent symptoms with weight loss, vomiting, swallowing pain, or black stools need urgent medical assessment.
Comparison
Pariet sits in a common clinical pathway for reflux and ulcer disease, and the “best” option depends on symptom pattern, prior response, and interaction risk.
| Option type | How it differs from Pariet | Typical use case |
|---|---|---|
| Proton pump inhibitors (PPIs) | Same drug class as Pariet, similar goal of strong acid suppression | Healing erosive disease, frequent GERD symptoms |
| H2-receptor blockers | Weaker acid suppression than PPIs, often more useful for mild/intermittent symptoms | Mild reflux, night-time breakthrough in selected cases |
| Antacids/alginate products | Fast symptom relief by neutralising or “rafting” acid; do not heal erosions alone | Occasional heartburn, add-on for breakthrough symptoms |
PPIs like Pariet often control symptoms better than H2 blockers, and long-term use needs a clear indication and periodic review because of class-associated risks described in guidelines [4].
Contraindications
- Allergy or hypersensitivity to rabeprazole (or to any tablet components)
- Pregnancy or breastfeeding, where use is generally avoided due to limited safety data in these periods
- Children under 12 years
- Concomitant use with atazanavir
- Severe liver dysfunction where specialist supervision and cautious dosing are needed
Not recommended for
Pariet is a strong acid suppressant, and its risk–benefit changes with your history and the other medicines you take. Clinicians also look for red flags and for medicines that depend on stomach acidity for absorption.
Drug interaction that matters: atazanavir should not be combined with rabeprazole because reduced stomach acid can lower atazanavir absorption and reduce antiviral effect. This interaction is treated as clinically significant in product information and specialist guidance.
Pariet may change the absorption of medicines where stomach acidity is part of the delivery system. Examples include some antifungals (like ketoconazole/itraconazole) and iron salts. Monitoring and timing adjustments are sometimes needed.
Side effects
Most people tolerate Pariet well, yet side effects do occur. Headache is one of the most common complaints, and mild nausea or stomach upset can appear early in treatment. Some people notice dizziness, and bowel habit can shift toward diarrhoea or constipation.
Skin rash or itching can signal an allergy. Stop the medicine and seek urgent medical advice if a rash is widespread, comes with facial swelling, or you feel short of breath.
Longer courses of PPIs are linked with class effects such as low magnesium, vitamin B12 deficiency, and a higher risk of certain gastrointestinal infections because acid is part of the body’s barrier against microbes [3]. Clinicians aim for the lowest effective dose for the shortest suitable duration.
Side effects that should trigger prompt review
- Persistent watery diarrhoea, fever, or blood in stool
- New severe abdominal pain
- Yellowing of the eyes or dark urine (possible liver issue)
- Unexplained bruising, extreme fatigue, or palpitations
Pariet can also hide symptoms of serious disease. New reflux after age 55, or reflux that returns quickly after stopping treatment, should be evaluated rather than repeatedly self-treating.
Common mistakes
Small habits can decide whether Pariet works smoothly.
- Taking it only “when needed” for daily reflux. PPIs work best when taken consistently, since they switch off active pumps rather than neutralising acid already present.
- Crushing or chewing tablets. Pariet tablets should be swallowed whole; damaging the protective design can reduce effect and increase stomach irritation.
- Using it to cover ongoing NSAID irritation. Painkillers like ibuprofen can keep injuring the stomach; acid suppression alone may not be enough.
- Continuing long-term without a clear reason. For many people, step-down or on-demand therapy is possible once symptoms are controlled and healing is confirmed.
- Ignoring alarm symptoms. Trouble swallowing, vomiting blood, black stools, unexplained weight loss, or persistent vomiting needs urgent assessment.
One more practical issue: if you also take a morning antibiotic regimen for H. pylori, timing gets messy. A written schedule avoids missed doses and improves eradication success.
Doctor opinions
In clinic, gastroenterologists and primary care doctors often use Pariet when symptoms suggest true acid-driven disease: burning behind the breastbone, sour regurgitation, reflux-triggered cough, or endoscopic evidence of erosive oesophagitis. Many patients feel better fast, yet doctors still plan therapy around healing timelines, not just symptom relief.
A pattern doctors see: people stop as soon as they feel well, then symptoms flare hard a week later. For erosive disease or ulcer healing, the course length matters, and stepping down (instead of an abrupt stop) can reduce rebound acid symptoms.
Doctors also screen for causes that mimic reflux: gallbladder disease, functional dyspepsia, medication irritation (NSAIDs), or cardiac pain. A PPI trial can be useful, but repeated cycles without a diagnosis is not a good long-term plan.
Frequently asked questions
Front view
Side view
Back view
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.
Pariet — Comparison with alternatives
Pariet Current
Dexilant Best rated
Asacol
Diarex Best price
Gasex
Reviews and Experiences
Sources
- European Medicines Agency (EMA) (2024). Rabeprazole: Summary of Product Characteristics (SmPC). ↑
- U.S. Food and Drug Administration (FDA) (2023). Rabeprazole sodium delayed-release tablets: Prescribing Information. ↑
- Cochrane (2022). Proton pump inhibitors for long-term use: benefits and harms (systematic review record). ↑
- National Institute for Health and Care Excellence (NICE) (2025). Gastro-oesophageal reflux disease and dyspepsia in adults: management (clinical guidance and evidence summaries). ↑
- World Health Organization (WHO) (2023). Proton pump inhibitors: medicinal information and safety considerations. ↑
